Dr Reddy's Lab CFO Umang Vohra says the company has performed well in all key geographies though Germany has underperformed a bit because of price erosion. The company is bullish on the second half of the fiscal, with 3-4 new launches in the US, and hopes its India business to grow by 18-20%.